Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Sell
13,452
-114
-0.8% -$2.98K 0.05% 388
2026
Q1
$381K Sell
13,566
-1,349
-9% -$35.9K 0.07% 303
2025
Q4
$371K Buy
14,915
+5,954
+66% +$150K 0.08% 275
2025
Q3
$229K Sell
8,961
-232,693
-96% -$5.74M 0.05% 337
2025
Q2
$5.87M Sell
241,654
-9,147
-4% -$213K 1.09% 22
2025
Q1
$5.97M Buy
250,801
+188,253
+301% +$4.93M 0.34% 65
2024
Q4
$1.63M Buy
+62,548
New +$1.7M 0.44% 52

Other funds holding PFE

GWN Securities's PFE Position: Q2 2026 in Review

GWN Securities reduced its Pfizer (PFE) stake by 0.84% in Q2 2026, selling an estimated $2.98K and leaving 13,452 shares worth $324K. The position accounts for 0.05% of the portfolio, ranked #388.

GWN Securities first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.97M in Q1 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • GWN Securities held 13,452 shares of Pfizer worth $324K as of Q2 2026.
  • GWN Securities sold 114 Pfizer shares in Q2 2026, an estimated $2.98K.
  • Pfizer made up 0.05% of GWN Securities's portfolio in Q2 2026, its #388 holding.
  • GWN Securities first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • GWN Securities's Pfizer position peaked at $5.97M in Q1 2025.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on GWN Securities's 13F filing for Q2 2026, filed 5 Aug 2026.